AbbVie Inc.
NYSE · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — |
| Investing | |||||||||
| Capital Expenditures | 1.21B | 974.0M | 777.0M | 695.0M | 787.0M | 798.0M | 552.0M | 638.0M | 529.0M |
| Acquisitions | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — |
| Financing | |||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — |
| Summary | |||||||||
| Free Cash Flow | 17.82B | 17.83B | 22.06B | 24.25B | 21.99B | 16.79B | 12.77B | 12.79B | 9.43B |
| Net Change in Cash | — | — | — | — | — | — | — | — | — |